---
schema_version: "secwatch.filing_event.v1"
accession: "0001077183-22-000085"
form_type: "8-K"
ticker: "NEO"
cik: "0001077183"
company_name: "NEOGENOMICS INC"
filed_at: "2022-05-16T23:59:59+00:00"
generated_at: "2026-06-25T13:34:41.273040+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# NeoGenomics appoints Lynn Tetrault as Interim CEO; Chief Strategy Officer departing May 27

## Summary
- Lynn Tetrault named Chair of the Board and Interim CEO, effective May 12, 2022; no compensation change.
- Company disbands Interim Office of the CEO; Tetrault previously served as Executive Chair since March.
- Board's external search for permanent CEO is 'on track' per Lead Independent Director Michael Kelly.
- Chief Strategy and Corporate Development Officer Douglas Brown leaves May 27 to pursue other interests.
- CFO William Bonello and Chief Culture Officer Jennifer Balliet remain in their roles.

## SEC filing metadata
- accession: 0001077183-22-000085
- form_type: 8-K
- ticker: NEO
- cik: 0001077183
- company_name: NEOGENOMICS INC
- filed_at: 2022-05-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000085/0001077183-22-000085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000085/neo-20220512.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001077183-22-000085
- JSON: https://secwatch.observer/filing/0001077183-22-000085.json
- Plain text: https://secwatch.observer/filing/0001077183-22-000085.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.